Polygiene Group delivered better than expected Q3 report on all key metrics.
Redeye sees a Q3 report matching our expectations on both sales and EBITA.
Redeye comments on Alligator's Q3 report. The main event since our last update was the ALG.
Redeye updates its estimates and valuation following ADDvise releasing its Q3 2024 report, which bro...
Redeye provides an update following Iconovo’s Q3 report.
Redeye’s view on the Q3 report. The organic growth was decent, with a gross margin that progressed.
Q3 EBIT -27% vs cons but orders +31% vs cons Positive Q4 guidance and longer-term outlook reiterated...
Redeye comments on Invisio’s Q3-results which were largely in line with our expectations while the o...
Underliggande portföljbolagen utvecklas väl under kvartalet drivet av fortsatt lönsam tillväxt.
Dovre Q3 results came in mixed relative to our estimates in the sense that Renewable Energy grew a l...
Solteq had lowered its guidance ahead of the earnings report and the net sales decline of 6.
Redeye's comments on Xbrane following its Q3 report noted softer-than-expected results; however, the...
Redeye retains its positive view of Fortnox following a solid Q3 report that meets our expectations.
Redeye leaves an initial comment following the Q3 report published by Magle this morning.
Adj. EBITA 1% vs ABGSC, -7% vs cons Weaker demand in Denmark to drive 2% neg.
